Clean Cells offers quality control and biological safety tests for biopharmaceutical products to assist in regulatory compliance, production of cell banks and GMP-grade BSL2 virus seed stock, supply of secure storage for these products and development and validation of bespoke analysis tools. Created in 2000, Clean Cells is now one of the largest European companies within this sector. Its strong customer focus and sizable product catalog (which expands annually) have made it a key player in the development of novel treatments and in personalized medicine. Clean Cells also stands out for its ability to react and adapt to its customers’ needs and the transparency of its production and quality control processes.